ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
| CFRXDelisted Stock | USD 1.18 0.08 6.35% |
Slightly above 61% of ContraFect Corp's investor base is looking to short. The analysis of current outlook of investing in ContraFect Corp suggests that many traders are alarmed regarding ContraFect Corp's prospects. ContraFect Corp's investing sentiment can be driven by a variety of factors including economic data, ContraFect Corp's earnings reports, geopolitical events, and overall market trends.
ContraFect |
CF-370 is the first engineered lysin therapeutic targeting Gram-negative pathogens allowed to enter a human trialYONKERS, N.Y., Oct. 16, 2023 -- ContraFect Corporation , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents , including lysins and amurin peptides, today announces that the U.S. Food and Drug Administration has notified the company that it has completed the safety review of its Investigation
Read at finance.yahoo.com
 |
ContraFect Corp Fundamental Analysis
We analyze ContraFect Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ContraFect Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ContraFect Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
ContraFect Corp is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
ContraFect Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ContraFect Corp stock to make a market-neutral strategy. Peer analysis of ContraFect Corp could also be used in its relative valuation, which is a method of valuing ContraFect Corp by comparing valuation metrics with similar companies.
Peers
ContraFect Corp Related Equities
| DRMA | Dermata Therapeutics | 2.73 | ||||
| QNRX | Quoin Pharmaceuticals | 1.69 | ||||
| PALI | Palisade Bio | 1.65 | ||||
| UNCY | Unicycive Therapeutics | 1.47 | ||||
| REVB | Revelation Biosciences | 1.33 | ||||
| NRBO | Neurobo Pharmaceuticals | 0.43 | ||||
| ALLR | Allarity Therapeutics | 0.90 | ||||
| VRAX | Virax Biolabs | 4.83 | ||||
| CNSP | Cns Pharmaceuticals | 8.33 | ||||
| WINT | Windtree Therapeutics | 13.11 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in ContraFect Stock
If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |